Advances in Emerging Hemorrhagic Fevers

A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Viral Pathogens".

Deadline for manuscript submissions: closed (30 October 2023) | Viewed by 156

Special Issue Editor


E-Mail Website
Guest Editor
Canadian Food Inspection Agency, National Center for Foreign Animal Disease, Winnipeg, MB, Canada
Interests: transboundary and emerging animal diseases
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear colleagues,

Viral hemorrhagic fevers (VHFs) are severe life-threatening infections in humans and animals. VHFs include zoonotic diseases, such as Yellow fever, Ebola, Lassa fever, Crimean–Congo hemorrhagic fever, and Rift Valley fever, which are transmitted between humans and livestock through various vectors, and animal diseases, such as African and classical swine fevers, rabbit hemorrhagic disease, epizootic hemorrhagic disease, and bluetongue in ruminants. They affect many organs, damage the blood vessels, and affect the body's ability to regulate itself. Some viral hemorrhagic fevers (VHFs) cause mild disease, but some, such as Ebola, Marburg, African swine fever, and rabbit hemorrhagic disease, cause severe disease and death. Zoonotic HFs continue to emerge and reemerge through zoonotic spillover events, resulting in high morbidity, mortality, and community dislocation. Globalization, along with international trade, travel, and climate change exacerbate the apparently increasing frequency of VHFs. Currently there are no cures for most VHFs, so ongoing research into VHFs is important for human and animal health.

This topic aims to shed light on recent developments related to viral hemorrhagic fevers in both humans and animals.

The Special Issue will address the following topics:

  • Epidemiology of VHFs, including surveillance and risk assessment;
  • Diagnostic methods of VHFs;
  • New treatments for VHFs;
  • Alleviation and prevention of VHFs, including vaccines and other medical countermeasures.

Both original research and review articles are welcomed.

Dr. Aruna Ambagala
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • emerging viral hemorrhagic fevers
  • humans
  • animals
  • zoonoses
  • fever

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop